RE: Synairgen CEO, Richard Marsden.8 Apr 2022 11:17
Hayashi
"The other board is full of detailed points as to why the trials as set up by SNG were almost shambolic in how they were structured and almost designed to fail. Rather above my pay grade. Presumably if Polygon or maybe Holgate lost faith in the ceo he would have to go ...and quickly."
"...but can't think of any logic to further invest unless you had additional knowledge/insight."
"However, the key point now is continual buying post 21/2, to increase their holding by more than 40% (from 18% to 26%). This rationale I struggle with as an investment case, unless there’s more hope than we know about."